Exciting new developments in upper-jaw reconstructive surgery

Looking at the patient as a whole in head and neck cancer

Chemoradiation in head and neck cancer and the need for big cancer centres

Neoadjuvant chemo best option for unresectable oral cavity cancer

Developing a guideline for treatment of late-stage oral cavity cancer

PDL1 expression in thymic tumours

Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Preventive neck lymph node surgery improves early oral cancer survival

Preventive neck lymph node surgery improves early oral cancer survival

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Pembrolizumab for head and neck cancer